Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.

Launched by UNIVERSITY HOSPITAL, CAEN · Jul 6, 2022

Keywords

ClinConnect Summary

This clinical trial, called EMPACOL, is exploring how the empathy shown by healthcare professionals (HCPs) affects the treatment outcomes for patients with non-metastatic colorectal cancer (CRC). The goal is to see if a strong, caring relationship between patients and their HCPs can lead to better results in the patients' treatment and overall quality of life. The study will look at both medical factors and how patients feel about the empathy they receive during their care.

To participate in this trial, patients need to be between 18 and 75 years old, speak French, and be part of a social security system. They should have non-metastatic colorectal cancer that is not complicated by other urgent medical issues. Participants will be asked to fill out questionnaires about their experiences and perceptions, which will help researchers understand the impact of empathy on their treatment journey. It's important to note that the trial is not yet recruiting participants, so there will be more information available soon for those who might be interested.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 to 75 years, French-speaking, affiliated to a social security system, having received informed information and not having expressed an unfavorable opinion to participate; carriers of non-metastatic and uncomplicated CRC (without occlusion/ perforation/bleeding), requiring elective therapeutic management. The included patients have a cognitive state capable of understanding and completing the questionnaires (autonomous completion).
• Exclusion Criteria:
• • Patients who were minors or older than 80 years, residing in a department outside Calvados or Manche, presenting a CRC other than adenocarcinoma and all metastatic forms or requiring emergency surgery (perforation, hemorrhage, occlusion), exclusive endoscopic treatment, or a missed-CRC discovered after surgery for non-oncological indications.
• • Patients with another neoplastic disease under treatment and/or evolving, patients with a history of inflammatory bowel disease (Crohn's disease, ulcerative colitis) and/or hereditary disease predisposing to CRC (Lynch syndrome, familial polyposis) or with severe cognitive impairment preventing proper comprehension of the questionnaires. Pregnant women will be excluded.